UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055554
Receipt number R000062492
Scientific Title Retrospective observational study of cancer excised with the clinical diagnosis of leukoplakia of the tongue
Date of disclosure of the study information 2024/09/20
Last modified on 2024/09/20 09:30:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of squamous cell carcinoma excised with clinical diagnosis of leukoplakia of the tongue

Acronym

Clinical study of squamous cell carcinoma excised with clinical diagnosis of leukoplakia of the tongue

Scientific Title

Retrospective observational study of cancer excised with the clinical diagnosis of leukoplakia of the tongue

Scientific Title:Acronym

Retrospective observational study of cancer excised with the clinical diagnosis of leukoplakia of the tongue

Region

Japan


Condition

Condition

tongue cancer

Classification by specialty

Oral surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to establish evidence-based treatment by examining the appropriateness of additional treatment and survival rates based on pathologic margins and treatment outcomes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local or resional recurrence

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who visited the Department of Oral and Maxillofacial Surgery, Nagasaki University Hospital between June 1, 2008 and March 31, 2023, and underwent resection with a clinical diagnosis of tongue leukoplakia and a histopathological diagnosis of squamous cell carcinoma of the tongue.

Key exclusion criteria

Cases with insufficient information due to poor documentation in the medical information record.
Cases that are not squamous cell carcinoma.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tomofumi
Middle name
Last name Naruse

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Oral and Maxillofacial Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki City

TEL

095-819-7698

Email

naruse12@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Tomofumi
Middle name
Last name Naruse

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Oral and Maxillofacial Surgery

Zip code

852-8588

Address

1-7-1 Sakamoto, Nagasaki City

TEL

095-819-7698

Homepage URL


Email

naruse12@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Clinical Research Review Board in Nagasaki University

Address

1-7-1 Sakamoto, Nagasaki city

Tel

095-819-7229

Email

gaibushikin@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 09 Month 20 Day

Date of IRB


Anticipated trial start date

2024 Year 09 Month 20 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2024 Year 09 Month 20 Day

Last modified on

2024 Year 09 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062492